TPO
Thyroid peroxidase
As of the edition of 20 October 2026, TPO (thyroid peroxidase, UniProt P07202) has 3 drugs tested at it and 3 companies on the list, 0 on route A and 0 on route B.
Sources: UniProt, ClinicalTrials.gov, ChEMBL, FDA Orange Book and Purple Book, Pharos.
The protein
- UniProt
- P07202
- How well studied
- Drug target: an approved drug acts on it
- Where it sits in the cell
- At a membrane
- Disease areas
- Hormones; Eye; Immune system; Cancer; Inherited and neonatal; Nervous system; Skin and connective tissue; Bones, joints and muscles
- Registered trials of its drugs
- 24
Drugs at this target
| Status | Count |
|---|---|
| Marketed | 3 |
| Total | 3 |
| Drug | Status | Furthest phase | US protection |
|---|---|---|---|
| Methimazole | Marketed | Phase 4 | none listed |
| Propylthiouracil | Marketed | Phase 2 | none listed |
| Carbimazole | Marketed | No phase stated | none listed |
3 of 3 drugs, the most tested first.
Companies at this target
| Where the company stands | Companies |
|---|---|
| Undetermined | 3 |
| Total on the list | 3 |